Companies / Santa Cruz Biotechnology / TCR β (G-11) FITC
Santa Cruz Biotechnology

TCR β (G-11) FITC | Santa Cruz Biotechnology

mouse monoclonal IgG1; TCR β Antibody (G-11) is an IgG1 κ mouse monoclonal TCR β antibody that detects TCR β of human origin by WB, IP, IF, IHC(P) and ELISA. TCR β Antibody (G-11) is available as the non-conjugated anti-TCR β antibody form, as well as multiple conjugated forms of anti-TCR β antibody, including agarose, HRP, PE, FITC and multiple Alexa Fluor® conjugates. The T cell antigen receptor (TCR) recognizes foreign antigens and translates such recognition events into intracellular signals that elicit a change in the cell from a dormant to an activated state. TCR is a heterodimer composed of either α and β or γ and δ chains. The vast majority of circulating T cells (95%) express the α/β heterodimer while roughly 2-5% express the γ/δ heterodimer. CD3 chains and the CD4 or CD8 co-receptors are also required for efficient signal transduction through the TCR. The TCR is expressed on T helper and T cytotoxic cells that can be distinguished by their expression of CD4 and CD8. T helper cells express CD4 proteins and T cytotoxic cells display CD8. CD4 is also expressed on cortical cells, mature medullary thymocytes, microglial cells and dendritic cells. CD4, also designated T4 and Leu 3, is a membrane glycoprotein that contains four extracellular immunoglobin-like domains. The TCR, in association with CD4, can bind class II MHC molecules presented by the antigen-presenting cells. The CD4 protein functions by increasing the avidity of the interaction between the TCR and an antigen-class II MHC complex.

Reviews


No reviews yet